» Articles » PMID: 38990426

Whole-body MRI in Oncology: Acquisition Protocols, Current Guidelines, and Beyond

Overview
Journal Radiol Med
Specialty Radiology
Date 2024 Jul 11
PMID 38990426
Authors
Affiliations
Soon will be listed here.
Abstract

Acknowledging the increasing use of whole-body magnetic resonance imaging (WB-MRI) in the oncological setting, we conducted a narrative review focusing on practical aspects of the examination and providing a synthesis of various acquisition protocols described in the literature. Firstly, we addressed the topic of patient preparation, emphasizing methods to enhance examination acceptance. This included strategies for reducing anxiety and patient distress, improving staff-patient interactions, and increasing overall patient comfort. Secondly, we analysed WB-MRI acquisition protocols recommended in existing imaging guidelines, such as MET-RADS-P, MY-RADS, and ONCO-RADS, and provided an overview of acquisition protocols reported in the literature regarding other expanding applications of WB-MRI in oncology, in patients with breast cancer, ovarian cancer, melanoma, colorectal and lung cancer, lymphoma, and cancers of unknown primary. Finally, we suggested possible acquisition parameters for whole-body images across MR systems from three different vendors.

Citing Articles

The Whole-Body MRI Reporting and Data System Guidelines for Prostate Cancer (MET-RADS-P), Multiple Myeloma (MY-RADS), and Cancer Screening (ONCO-RADS).

Parillo M, Mallio C Cancers (Basel). 2025; 17(2).

PMID: 39858056 PMC: 11763526. DOI: 10.3390/cancers17020275.


Role of Imaging in Multiple Myeloma: A Potential Opportunity for Quantitative Imaging and Radiomics?.

Michalska-Foryszewska A, Rogowska A, Kwiatkowska-Miernik A, Sklinda K, Mruk B, Hus I Cancers (Basel). 2024; 16(23).

PMID: 39682285 PMC: 11640347. DOI: 10.3390/cancers16234099.

References
1.
Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka J, Melhem E . A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol. 1997; 169(6):1655-61. DOI: 10.2214/ajr.169.6.9393186. View

2.
Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V . Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging. 2000; 11(4):343-50. DOI: 10.1002/(sici)1522-2586(200004)11:4<343::aid-jmri1>3.0.co;2-p. View

3.
Kwee T, Takahara T, Ochiai R, Nievelstein R, Luijten P . Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol. 2008; 18(9):1937-52. PMC: 2516183. DOI: 10.1007/s00330-008-0968-z. View

4.
Summers P, Saia G, Colombo A, Pricolo P, Zugni F, Alessi S . Whole-body magnetic resonance imaging: technique, guidelines and key applications. Ecancermedicalscience. 2021; 15:1164. PMC: 7929776. DOI: 10.3332/ecancer.2021.1164. View

5.
Morone M, Antonietta Bali M, Tunariu N, Messiou C, Blackledge M, Grazioli L . Whole-Body MRI: Current Applications in Oncology. AJR Am J Roentgenol. 2017; 209(6):W336-W349. DOI: 10.2214/AJR.17.17984. View